Home
Issues
2021
August 2021 Vol 11, No 4
June 2021 Vol 11, No 3
April 2021 Vol 11, No 2
March 2021 Vol 11 Special Feature
February 2021 Vol 11, No 1
2020
December 2020, Vol 10, No 6
October 2020, Vol 10, No 5
August 2020, Vol 10, No 4
June 2020, Vol 10, No 3
April 2020 Vol 10, No 2
February 2020 Vol 10, No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
Categories
Conference Correspondent
AACR & ASCO 2021 - Midyear Review
ASCO 2021 Breast Cancer Highlights
ASCO Highlights
ASH Highlights
ESMO Highlights
SABCS Highlights
Web Exclusives
All Web Exclusives
Interview with the Innovators
FDA Approvals
Online First
Videos
Press Releases
Lung Cancer Monthly Minutes
Melanoma Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview Guidelines
Letters to the Editor Instructions
Peer Review Application
Submit a Manuscript
About
About JHOP
About GreenhillHC
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Advertise
Subscribe
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below.
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
JHOP Print Edition
We will request your mailing address on the next page.
JHOP E-Newsletters & Communications
TOP Print Edition
We will request your mailing address on the next page.
TOP E-Newsletters & Communications
I have reviewed and consent to the terms of
JHOP
's
Privacy Policy
, and
JHOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
Home
Issues
2021
August 2021 Vol 11, No 4
June 2021 Vol 11, No 3
April 2021 Vol 11, No 2
March 2021 Vol 11 Special Feature
February 2021 Vol 11, No 1
2020
December 2020, Vol 10, No 6
October 2020, Vol 10, No 5
August 2020, Vol 10, No 4
June 2020, Vol 10, No 3
April 2020 Vol 10, No 2
February 2020 Vol 10, No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
Categories
Conference Correspondent
AACR & ASCO 2021 - Midyear Review
ASCO 2021 Breast Cancer Highlights
ASCO Highlights
ASH Highlights
ESMO Highlights
SABCS Highlights
Web Exclusives
All Web Exclusives
Interview with the Innovators
FDA Approvals
Online First
Videos
Press Releases
Lung Cancer Monthly Minutes
Melanoma Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview Guidelines
Letters to the Editor Instructions
Peer Review Application
Submit a Manuscript
About
About JHOP
About GreenhillHC
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Advertise
ASCO 2021 - Breast Cancer
ASCO 2021 - Breast Cancer
Inflammatory Responses to Neoadjuvant Chemotherapy Can Be Regulated by Moderate Physical Exercise Prior to Surgery
Read More
ASCO 2021 - Breast Cancer
Assessment of Factors That Influence Psychosocial Function in Breast Cancer Patients After Treatment
Read More
ASCO 2021 - Breast Cancer
Identification of Biomarkers for HER2-Negative Advanced Breast Cancer Is Influenced by Race: A Real-World Study
Read More
ASCO 2021 - Breast Cancer
Treatment with Alpelisib plus Fulvestrant Achieves Long-Term Disease Control in Endocrine-Resistant (HR-Positive/HER2-Negative) Advanced Breast Cancer
Read More
ASCO 2021 - Breast Cancer
Behavioral Interventions Demonstrate Improved Long-Term Adherence to Adjuvant Endocrine Therapy Among Women with HR-Positive Breast Cancer
Read More
ASCO 2021 - Breast Cancer
Assessment of Oncology Patient Satisfaction with Telehealth Visits
Read More
ASCO 2021 - Breast Cancer
Need for Improved Access to Cancer Screening Tools for Minorities with Socioeconomic Barriers to Medical Care
Read More
ASCO 2021 - Breast Cancer
Novel and Clinically Relevant Measure of Perceived Fatigability Reveals Benefit of Exercise in Breast Cancer Survivors
Read More
ASCO 2021 - Breast Cancer
Association of Stage of Breast Cancer Diagnosis and Socioeconomic Status in French Women
Read More
ASCO 2021 - Breast Cancer
Alpelisib Overcomes Resistance to CDK4/6 Inhibitors in HR-Positive/HER2-Negative Advanced Breast Cancer Patients
Read More
1
2
Page 1 of 2
Results 1 - 10 of 15
Privacy policy
Terms of Use
Home
About
Subscribe
Advertise
Contact Us
Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.
